GB8500504D0 - Pharmaceutical forms - Google Patents

Pharmaceutical forms

Info

Publication number
GB8500504D0
GB8500504D0 GB858500504A GB8500504A GB8500504D0 GB 8500504 D0 GB8500504 D0 GB 8500504D0 GB 858500504 A GB858500504 A GB 858500504A GB 8500504 A GB8500504 A GB 8500504A GB 8500504 D0 GB8500504 D0 GB 8500504D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical forms
pharmaceutical
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB858500504A
Other versions
GB2153225A (en
GB2153225B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Gentili SpA
Original Assignee
Istituto Gentili SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Gentili SpA filed Critical Istituto Gentili SpA
Publication of GB8500504D0 publication Critical patent/GB8500504D0/en
Publication of GB2153225A publication Critical patent/GB2153225A/en
Application granted granted Critical
Publication of GB2153225B publication Critical patent/GB2153225B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB08500504A 1984-01-12 1985-01-09 Effervescent preparations containing diphosphonates Expired GB2153225B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19122/84A IT1195993B (en) 1984-01-12 1984-01-12 PHARMACEUTICAL FORMS BASED ON DIPHOSPHONATES

Publications (3)

Publication Number Publication Date
GB8500504D0 true GB8500504D0 (en) 1985-02-13
GB2153225A GB2153225A (en) 1985-08-21
GB2153225B GB2153225B (en) 1987-08-05

Family

ID=11154925

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08500504A Expired GB2153225B (en) 1984-01-12 1985-01-09 Effervescent preparations containing diphosphonates

Country Status (4)

Country Link
DE (1) DE3500670A1 (en)
FR (1) FR2558060B1 (en)
GB (1) GB2153225B (en)
IT (1) IT1195993B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3804686A1 (en) * 1988-02-15 1989-08-24 Henkel Kgaa MEDICAMENT WITH A COMBINATION OF CYTOSTATIKA BZW. HORMONTHERAPEUTICS AND PHOSPHONOR DERIVATIVES
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
ATE541575T1 (en) * 2002-03-06 2012-02-15 Effrx Pharmaceuticals Sa Effervescent TABLETS CONTAINING ALENDRONATE
ES2532393T3 (en) 2002-05-10 2015-03-26 F. Hoffmann-La Roche Ag Bisphosphonic acids for treatment and prevention of osteoporosis
DE60315514T3 (en) 2002-12-20 2012-04-26 F. Hoffmann-La Roche Ag HIGH-DOSED IBANDRONATE FORMULATION
WO2006100527A1 (en) * 2005-03-24 2006-09-28 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Effervescent tablet containing sodium alendronate and related use and process
CA2820019A1 (en) * 2010-12-06 2012-06-14 Effrx Pharmaceuticals Sa Stable effervescent bisphosphonate formulations with rapid solubilization characteristics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE622680A (en) *
DE2360797C2 (en) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmaceutical preparations
DE2405254C2 (en) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Use of 3-amino-1-hydroxypropane-1, 1-diphosphonic acid or its water-soluble salts for influencing calcium metabolic disorders in the human or animal body
DE2813121A1 (en) * 1977-03-29 1978-10-12 Procter & Gamble Di:chloromethane di:phosphonate compsns. - for stimulating collagen formation and treating of healing wounds and rheumatic and allied disorders
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
GB2079285B (en) * 1980-07-09 1984-05-23 Symphar Sa Dipthosphonate derivatives and pahrmaceutical compositions containing them
IT1194748B (en) * 1981-02-12 1988-09-28 Gentili Ist Spa PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPATHIES
DE3225468A1 (en) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonic acid derivatives and pharmaceutical preparations containing them
DE19675047I2 (en) * 1982-04-15 2003-06-12 Gentili Ist Spa Pharmaceutical composition containing 4-amino-1-hydroxybutane-1, 1-biphosphonic acid

Also Published As

Publication number Publication date
FR2558060B1 (en) 1988-02-19
IT1195993B (en) 1988-11-03
GB2153225A (en) 1985-08-21
FR2558060A1 (en) 1985-07-19
DE3500670A1 (en) 1985-07-18
GB2153225B (en) 1987-08-05
IT8419122A0 (en) 1984-01-12
DE3500670C2 (en) 1992-01-16

Similar Documents

Publication Publication Date Title
GB8518979D0 (en) Pharmaceutical preparation
GB2153678B (en) Pharmaceutical composition
GB8517577D0 (en) Medicaments
EP0163178A3 (en) Pharmaceutical composition
GB2153677B (en) Pharmaceutical composition
GB8500504D0 (en) Pharmaceutical forms
GB8513641D0 (en) Pharmaceutical composition
ZA854564B (en) Pharmaceutical agents
GB8508000D0 (en) Drug combinations
GB8525673D0 (en) Pharmaceutical agent
GB8521395D0 (en) Medicament
GB8529160D0 (en) Pharmaceutical compounds
GB8509165D0 (en) Pharmaceutical agent
GB2153676B (en) Pharmaceutical composition
GB8518565D0 (en) Pharmaceutical composition
GB8510673D0 (en) Drug combinations
KR870001005Y1 (en) Drug case
GB8412503D0 (en) Pharmaceutical compounds
GB8414775D0 (en) Pharmaceutical compounds
GB8414776D0 (en) Pharmaceutical compounds
GB8726328D0 (en) Pharmaceutical compounds
IE843185L (en) Pharmaceutical preparation
GB8409784D0 (en) Pharmaceutical substances
GB8422135D0 (en) Medicament
GB8424510D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20050108